[Decapeptyl 3.57mg in the therapy of the fibromatous uterus. Authors' contribution].
Thirty women in their reproductive age who were diagnosed for leiomyomata uteri were treated for 6 months with Triptorelin slow release, 3.75 mg, every 28 days, i.m. The results obtained were highly satisfactory and were confirmed by ultrasound scanning and clinical examination. The drug was extremely well tolerated by patients and the side-effects reported never required the interruption of treatment.
Sannito
F
F
Divisione Ostetricia-Ginecologia, Ospedale Umberto, Mestre.
Luppari
T
T
D000328:Adult; D000367:Age Factors; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy*; D017329:Triptorelin Pamoate / Q000008:administration & dosage*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D017329:Triptorelin Pamoate
Decapeptyl 3,75 mg nella terapia dell'utero fibromatoso. Nostro contributo.